Paper39145348
Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk.
Davies C and 12 others. Schizophr Bull Open, 2023. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk. Papers, record 39145348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39145348
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MR/J012149/1 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References83
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32159746 | Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention. | JAMA Psychiatry | 2020 | https://conductscience.org/library/papers/32159746 | PubMed |
| 2 | 31771861 | Hippocampal Pathology in Clinical High-Risk Patients and the Onset of Schizophrenia. | Biol Psychiatry | 2020 | https://conductscience.org/library/papers/31771861 | PubMed |
| 3 | 21536967 | Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis. | Arch Gen Psychiatry | 2011 | https://conductscience.org/library/papers/21536967 | PubMed |
| 4 | 31681029 | Pan-London Network for Psychosis-Prevention (PNP). | Front Psychiatry | 2019 | https://conductscience.org/library/papers/31681029 | PubMed |
| 5 | 36696108 | Why Hippocampal Glutamate Levels Are Elevated in Schizophrenia. | JAMA Psychiatry | 2023 | https://conductscience.org/library/papers/36696108 | PubMed |
| 6 | 33414100 | The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ9-Tetrahydrocannabinol and Cannabidiol. | Biol Psychiatry Cogn Neurosci Neuroimaging | 2021 | https://conductscience.org/library/papers/33414100 | PubMed |
| 7 | 28115738 | Glutamate imaging (GluCEST) reveals lower brain GluCEST contrast in patients on the psychosis spectrum. | Mol Psychiatry | 2017 | https://conductscience.org/library/papers/28115738 | PubMed |
| 8 | 19349314 | Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. | Arch Gen Psychiatry | 2009 | https://conductscience.org/library/papers/19349314 | PubMed |
| 9 | 26970363 | Human Laboratory Studies on Cannabinoids and Psychosis. | Biol Psychiatry | 2016 | https://conductscience.org/library/papers/26970363 | PubMed |
| 10 | 22213786 | Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. | Arch Gen Psychiatry | 2012 | https://conductscience.org/library/papers/22213786 | PubMed |
| 11 | 31618752 | Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging study. | Neuropsychopharmacology | 2020 | https://conductscience.org/library/papers/31618752 | PubMed |
| 12 | 32921544 | Outreach and support in South-London (OASIS) 2001-2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis. | Eur Neuropsychopharmacol | 2020 | https://conductscience.org/library/papers/32921544 | PubMed |
| 13 | 26568030 | Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis. | Psychol Med | 2016 | https://conductscience.org/library/papers/26568030 | PubMed |
| 14 | 34584230 | Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies. | Mol Psychiatry | 2022 | https://conductscience.org/library/papers/34584230 | PubMed |
| 15 | 32848931 | Neurovascular Uncoupling in Schizophrenia: A Bimodal Meta-Analysis of Brain Perfusion and Glucose Metabolism. | Front Psychiatry | 2020 | https://conductscience.org/library/papers/32848931 | PubMed |
| 16 | 21307846 | Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. | Neuropsychopharmacology | 2011 | https://conductscience.org/library/papers/21307846 | PubMed |
| 17 | 34505389 | Dopamine and glutamate in individuals at high risk for psychosis: a meta-analysis of in vivo imaging findings and their variability compared to controls. | World Psychiatry | 2021 | https://conductscience.org/library/papers/34505389 | PubMed |
| 18 | 33941857 | Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes. | Neuropsychopharmacology | 2021 | https://conductscience.org/library/papers/33941857 | PubMed |
| 19 | 30167644 | Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis: A Randomized Clinical Trial. | JAMA Psychiatry | 2018 | https://conductscience.org/library/papers/30167644 | PubMed |
| 20 | 20638047 | Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis. | Biol Psychiatry | 2010 | https://conductscience.org/library/papers/20638047 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40259403 | Effect of cannabinoids on glutamate levels in the human brain: a systematic review and meta-analysis. | J Cannabis Res | 2025 | https://conductscience.org/library/papers/40259403 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39145348
GET https://conductscience.org/api/papers/v1/39145348/references?page=2